Free Trial
→ Trump wipes out trillions overnight… (From Porter & Company) (Ad) Buy PRLB Stock  Free PRLB Stock Alerts

Proto Labs (PRLB) Financials

Proto Labs logo
$37.41 -2.16 (-5.46%)
Closing price 05/22/2025 03:59 PM Eastern
Extended Trading
$37.48 +0.07 (+0.18%)
As of 09:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Proto Labs

Annual Income Statements for Proto Labs

This table shows Proto Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Income / (Loss) Attributable to Common Shareholders		 17 17 -103 33 51 64 77 52 43 47 42
Consolidated Net Income / (Loss)		 17 17 -103 33 51 64 77 52 43 47 42
Net Income / (Loss) Continuing Operations		 17 17 -103 33 51 64 77 52 43 47 42
Total Pre-Tax Income 		25 28 -98 40 63 81 92 74 64 68 61
Total Operating Income		 20 28 -98 40 60 80 89 72 62 67 61
Total Gross Profit		 223 222 215 223 218 235 239 194 167 154 128
Total Revenue		 501 504 488 488 434 459 446 344 298 264 210
Operating Revenue		 501 504 488 488 434 459 446 344 298 264 210
Total Cost of Revenue		 278 282 273 265 217 223 207 151 131 110 81
Operating Cost of Revenue		 278 282 273 265 217 223 207 151 131 110 81
Total Operating Expenses		 203 194 313 182 158 155 150 122 105 87 68
Selling, General & Admin Expense		 64 66 68 56 52 50 53 41 37 30 22
Marketing Expense		 92 88 83 82 69 73 69 57 46 39 29
Research & Development Expense		 41 40 38 44 37 33 29 24 22 18 17
Impairment Charge		 0.00 0.00 118 0.00 0.00 - - - - - -
Restructuring Charge		 5.59 0.22 6.92 - - - - - - - -
Total Other Income / (Expense), net		 4.76 -0.22 0.11 -0.16 3.11 1.34 2.76 2.21 2.45 0.71 0.00
Other Income / (Expense), net		 4.76 -0.22 0.11 -0.16 3.11 1.34 2.76 2.21 2.45 0.71 0.00
Income Tax Expense		 8.08 11 5.59 6.81 12 18 15 23 22 21 19
Basic Earnings per Share		 $0.66 $0.66 ($3.77) $1.21 $1.90 $2.37 $2.84 $1.94 $1.62 $1.79 $1.62
Weighted Average Basic Shares Outstanding		 25.10M 26.19M 27.41M 27.62M 26.74M 26.87M 26.98M 26.65M 26.37M 26.01M 25.69M
Diluted Earnings per Share		 $0.66 $0.66 ($3.77) $1.21 $1.89 $2.35 $2.81 $1.93 $1.61 $1.77 $1.60
Weighted Average Diluted Shares Outstanding		 25.21M 26.22M 27.41M 27.65M 26.90M 27.05M 27.28M 26.85M 26.56M 26.32M 26.10M
Weighted Average Basic & Diluted Shares Outstanding		 24.23M 25.72M 26.68M 27.47M 27.60M 26.79M 27M 26.70M 26.40M 26M 25.70M

Quarterly Income Statements for Proto Labs

This table shows Proto Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 3.60 -0.40 7.19 4.54 5.27 6.99 7.95 -0.38 2.66 -115 3.95
Consolidated Net Income / (Loss)		 3.60 -0.40 7.19 4.54 5.27 6.99 7.95 -0.38 2.66 -115 3.95
Net Income / (Loss) Continuing Operations		 3.60 -0.40 7.19 4.54 5.27 6.99 7.95 -0.38 2.66 -115 3.95
Total Pre-Tax Income 		5.99 -0.28 9.87 7.36 7.73 9.94 11 2.24 5.04 -117 6.03
Total Operating Income		 4.53 -1.50 8.58 6.00 6.83 8.40 10 5.61 3.75 -117 6.06
Total Gross Profit		 56 52 57 57 57 56 59 53 54 49 54
Total Revenue		 126 122 126 126 128 125 131 122 126 116 122
Operating Revenue		 126 122 126 126 128 125 131 122 126 116 122
Total Cost of Revenue		 71 70 68 69 70 69 71 69 72 67 68
Operating Cost of Revenue		 71 70 68 69 70 69 71 69 72 67 68
Total Operating Expenses		 51 53 49 51 51 47 49 48 50 166 48
Selling, General & Admin Expense		 17 15 16 17 16 16 17 16 17 18 16
Marketing Expense		 24 23 23 23 23 22 22 22 22 21 21
Research & Development Expense		 11 9.70 9.77 11 11 9.49 10 9.87 11 8.91 9.31
Other Operating Expenses / (Income)		 -0.04 - 0.00 0.00 0.00 - 0.02 0.10 0.07 - 1.19
Total Other Income / (Expense), net		 1.45 1.21 1.29 1.36 0.90 1.54 0.32 -3.37 1.29 0.43 -0.02
Other Income / (Expense), net		 1.45 1.21 1.29 1.36 0.90 1.54 0.32 -3.37 1.29 0.43 -0.02
Income Tax Expense		 2.39 0.12 2.68 2.82 2.46 2.95 2.78 2.62 2.38 -1.64 2.08
Basic Earnings per Share		 $0.15 ($0.02) $0.29 $0.18 $0.21 $0.26 $0.31 ($0.01) $0.10 ($4.19) $0.14
Weighted Average Basic Shares Outstanding		 24.14M 25.10M 24.98M 25.31M 25.62M 26.19M 26.02M 26.21M 26.58M 27.41M 27.51M
Diluted Earnings per Share		 $0.15 ($0.01) $0.29 $0.18 $0.20 $0.26 $0.31 ($0.01) $0.10 ($4.19) $0.14
Weighted Average Diluted Shares Outstanding		 24.44M 25.21M 25.02M 25.37M 25.78M 26.22M 26.03M 26.21M 26.61M 27.41M 27.51M
Weighted Average Basic & Diluted Shares Outstanding		 23.77M 24.23M 24.51M 25.15M 25.32M 25.72M 25.79M 26.10M 26.20M 26.68M 27.12M

Annual Cash Flow Statements for Proto Labs

This table details how cash moves in and out of Proto Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Change in Cash & Equivalents		 5.28 27 -9.37 -62 2.38 40 48 -32 21 4.32 0.29
Net Cash From Operating Activities		 78 73 62 55 107 116 123 82 77 64 57
Net Cash From Continuing Operating Activities		 78 73 62 55 107 116 123 82 77 64 57
Net Income / (Loss) Continuing Operations		 17 17 -103 33 51 64 77 52 43 47 42
Consolidated Net Income / (Loss)		 17 17 -103 33 51 64 77 52 43 47 42
Depreciation Expense		 36 38 39 40 33 31 27 18 17 14 11
Non-Cash Adjustments To Reconcile Net Income		 20 20 137 19 15 11 9.64 8.92 5.69 5.74 0.34
Changes in Operating Assets and Liabilities, net		 5.82 -1.93 -11 -38 8.76 10 9.58 1.52 10 -3.52 2.58
Net Cash From Investing Activities		 -14 -4.55 -43 -95 -95 -44 -63 -124 -61 -64 -63
Net Cash From Continuing Investing Activities		 -14 -4.55 -43 -95 -95 -44 -63 -124 -61 -64 -63
Purchase of Property, Plant & Equipment		 -9.17 -28 -22 -34 -47 -62 -87 -33 -34 -44 -44
Purchase of Investments		 -25 -1.00 -47 -16 -116 -50 -42 -29 -89 -66 -60
Sale of Property, Plant & Equipment		 0.03 0.70 4.11 0.00 0.00 - - - - - -
Sale and/or Maturity of Investments		 21 24 21 83 68 68 65 48 62 52 74
Net Cash From Financing Activities		 -59 -42 -28 -22 -11 -32 -10 9.19 5.32 4.70 7.04
Net Cash From Continuing Financing Activities		 -59 -42 -28 -22 -11 -32 -10 9.19 5.32 4.70 7.04
Repayment of Debt		 -0.30 -0.31 -0.53 -0.56 -0.15 0.00 -5.00 0.00 0.00 -0.15 -1.05
Repurchase of Common Equity		 -60 -44 -30 -23 -15 -34 -12 -4.41 0.00 0.00 -
Issuance of Common Equity		 4.02 3.84 3.95 5.86 7.56 4.39 8.94 8.60 5.72 6.25 4.82
Other Financing Activities, net		 -2.00 -1.44 -1.68 -4.23 -3.44 -2.49 -2.14 0.00 - - 4.47
Effect of Exchange Rate Changes		 -0.42 0.37 -0.44 -0.05 - 0.05 - 0.95 -0.92 -0.88 -0.46
Cash Interest Paid		 0.14 1.06 0.10 0.03 0.02 0.01 0.04 0.02 0.00 0.01 0.02
Cash Income Taxes Paid		 14 16 19 7.58 5.65 4.00 9.97 19 9.80 20 12

Quarterly Cash Flow Statements for Proto Labs

This table details how cash moves in and out of Proto Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 -6.38 1.20 -8.28 3.35 9.01 0.29 17 4.44 5.49 -2.80 4.70
Net Cash From Operating Activities		 18 17 25 14 21 17 24 9.29 23 11 21
Net Cash From Continuing Operating Activities		 18 17 25 14 21 17 24 9.29 23 11 21
Net Income / (Loss) Continuing Operations		 3.60 -0.40 7.19 4.54 5.27 6.99 7.95 -0.38 2.66 -115 3.95
Consolidated Net Income / (Loss)		 3.60 -0.40 7.19 4.54 5.27 6.99 7.95 -0.38 2.66 -115 3.95
Depreciation Expense		 8.69 8.82 8.91 8.97 9.10 9.32 9.33 9.50 9.39 9.44 9.71
Non-Cash Adjustments To Reconcile Net Income		 4.22 6.63 4.46 4.25 4.26 4.37 4.66 7.43 3.98 122 4.78
Changes in Operating Assets and Liabilities, net		 1.87 2.24 4.20 -3.32 2.70 -3.45 2.23 -7.26 6.55 -6.05 2.08
Net Cash From Investing Activities		 -2.91 -2.90 -14 -0.75 4.42 -14 2.06 3.43 4.38 0.27 -6.85
Net Cash From Continuing Investing Activities		 -2.91 -2.90 -14 -0.75 4.42 -14 2.06 3.43 4.38 0.27 -6.85
Purchase of Property, Plant & Equipment		 -1.26 -0.83 -1.56 -4.20 -2.59 -18 -3.11 -3.39 -3.44 -5.27 -10
Purchase of Investments		 -6.55 -6.98 - - - -1.00 - - - -1.00 -6.99
Sale of Property, Plant & Equipment		 0.00 - 0.00 0.01 0.02 0.01 0.07 0.43 0.19 0.88 3.23
Sale and/or Maturity of Investments		 4.91 4.92 5.29 3.44 6.98 4.75 5.10 6.39 7.63 5.66 7.30
Net Cash From Financing Activities		 -22 -13 -19 -10 -17 -3.12 -9.07 -8.06 -22 -15 -7.97
Net Cash From Continuing Financing Activities		 -22 -13 -19 -10 -17 -3.12 -9.07 -8.06 -22 -15 -7.97
Repayment of Debt		 -0.08 -0.08 -0.07 -0.07 -0.07 -0.07 -0.07 -0.08 -0.08 -0.11 -0.14
Repurchase of Common Equity		 -21 -14 -19 -11 -16 -4.90 -8.99 -8.95 -21 -17 -7.84
Issuance of Common Equity		 0.29 - - - - - - - - 1.64 -
Other Financing Activities, net		 -1.25 -2.17 - 0.71 -0.53 -1.99 -0.01 0.96 -0.40 -0.07 -
Effect of Exchange Rate Changes		 0.08 -0.65 0.41 -0.05 -0.12 0.61 -0.16 -0.21 0.13 1.54 -1.01

Annual Balance Sheets for Proto Labs

This table presents Proto Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Assets		 744 772 802 929 744 674 619 519 414 361 287
Total Current Assets		 195 201 187 183 242 236 215 165 158 138 108
Cash & Equivalents		 89 84 57 66 128 125 85 37 69 48 43
Short-Term Investments		 14 19 24 12 34 35 47 57 39 33 31
Accounts Receivable		 67 73 76 80 58 57 59 52 34 36 24
Inventories, net		 12 14 14 13 11 10 10 11 9.31 9.77 6.19
Prepaid Expenses		 10 9.12 13 11 11 8.23 8.57 6.27 5.70 5.22 3.41
Current Deferred & Refundable Income Taxes		 2.91 2.23 4.04 1.32 0.54 0.00 5.76 1.83 0.45 6.03 0.00
Plant, Property, & Equipment, net		 227 254 258 280 283 264 228 166 139 125 92
Total Noncurrent Assets		 321 318 358 465 220 174 176 187 117 98 88
Long-Term Investments		 18 8.02 26 14 59 13 24 37 84 65 54
Noncurrent Note & Lease Receivables		 0.69 0.96 18 1.90 2.40 0.00 0.00 - - - -
Goodwill		 274 274 274 401 129 129 129 129 29 29 29
Intangible Assets		 21 26 31 38 14 17 20 19 2.66 3.34 4.08
Other Noncurrent Operating Assets		 7.52 9.48 8.62 9.90 15 14 3.44 2.67 0.93 0.52 0.23
Total Liabilities & Shareholders' Equity		 744 772 802 929 744 674 619 519 414 361 287
Total Liabilities		 73 77 105 100 100 88 77 58 34 33 21
Total Current Liabilities		 53 50 72 55 50 48 53 44 23 26 19
Accounts Payable		 16 16 17 25 18 17 17 16 11 14 7.88
Accrued Expenses		 20 17 22 12 16 11 17 8.41 4.44 2.63 2.72
Current Employee Benefit Liabilities		 17 15 13 14 12 15 18 12 7.67 9.99 6.07
Other Current Liabilities		 1.60 1.88 19 3.85 3.82 3.34 0.00 - - - -
Total Noncurrent Liabilities		 20 27 33 45 50 40 25 14 11 7.13 2.73
Noncurrent Deferred & Payable Income Tax Liabilities		 14 19 26 36 34 26 20 6.97 7.00 4.24 1.36
Other Noncurrent Operating Liabilities		 6.53 8.64 6.62 9.30 16 14 4.59 4.62 3.98 2.89 1.36
Total Equity & Noncontrolling Interests		 670 695 698 828 644 586 541 461 380 328 266
Total Preferred & Common Equity		 670 695 698 828 644 586 541 461 380 328 266
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 670 695 698 828 644 586 541 461 380 328 266
Common Stock		 454 467 474 469 285 268 259 242 214 199 181
Retained Earnings		 244 256 258 377 363 325 291 225 177 134 87
Accumulated Other Comprehensive Income / (Loss)		 -28 -28 -34 -17 -3.42 -7.02 -8.49 -5.23 -11 -5.21 -2.93

Quarterly Balance Sheets for Proto Labs

This table presents Proto Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets		 737 754 758 770 784 777 791 907
Total Current Assets		 194 193 208 210 205 185 189 192
Cash & Equivalents		 83 88 96 93 83 66 62 59
Short-Term Investments		 14 13 17 17 19 20 23 25
Accounts Receivable		 74 69 71 78 78 75 78 81
Inventories, net		 13 12 12 13 14 14 14 15
Prepaid Expenses		 9.59 10 10 9.43 8.72 8.50 11 12
Current Deferred & Refundable Income Taxes		 0.86 0.67 1.40 0.64 0.89 0.87 0.82 0.76
Plant, Property, & Equipment, net		 221 238 244 248 243 249 254 260
Total Noncurrent Assets		 322 323 307 312 337 343 349 455
Long-Term Investments		 19 17 0.00 3.26 12 16 20 29
Noncurrent Note & Lease Receivables		 0.63 0.76 0.83 0.89 17 17 17 1.52
Goodwill		 274 274 274 274 274 274 274 384
Intangible Assets		 21 23 23 24 27 28 30 32
Other Noncurrent Operating Assets		 7.02 8.01 8.63 9.04 7.08 7.82 8.09 8.48
Total Liabilities & Shareholders' Equity		 737 754 758 770 784 777 791 907
Total Liabilities		 81 74 73 82 99 95 108 96
Total Current Liabilities		 62 54 51 58 75 66 78 61
Accounts Payable		 16 15 16 15 18 16 20 17
Accrued Expenses		 24 18 18 21 21 19 23 25
Current Deferred & Payable Income Tax Liabilities		 1.63 0.99 - 3.88 1.14 0.35 1.93 0.01
Current Employee Benefit Liabilities		 19 18 16 16 16 12 15 15
Other Current Liabilities		 1.44 1.76 1.84 1.85 18 18 19 3.26
Total Noncurrent Liabilities		 19 20 22 24 25 28 30 35
Noncurrent Deferred & Payable Income Tax Liabilities		 12 13 15 16 17 21 23 27
Other Noncurrent Operating Liabilities		 6.50 7.35 7.44 7.58 7.56 7.51 6.60 8.51
Total Equity & Noncontrolling Interests		 657 680 685 687 685 683 683 811
Total Preferred & Common Equity		 657 680 685 687 685 683 683 811
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 657 680 685 687 685 683 683 811
Common Stock		 447 454 461 463 464 465 465 477
Retained Earnings		 237 253 253 253 251 247 251 381
Accumulated Other Comprehensive Income / (Loss)		 -27 -27 -29 -29 -30 -29 -33 -47

Annual Metrics And Ratios for Proto Labs

This table displays calculated financial ratios and metrics derived from Proto Labs' official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -0.59% 3.17% 0.06% 12.36% -5.30% 2.95% 29.35% 15.58% 12.85% 26.02% 28.49%
EBITDA Growth		 -7.64% 212.02% -172.46% -15.56% -14.74% -5.66% 26.40% 13.38% -0.41% 13.71% 20.74%
EBIT Growth		 -11.73% 128.56% -343.57% -36.16% -22.47% -11.41% 23.13% 15.90% -5.36% 12.11% 17.36%
NOPAT Growth		 -22.83% 125.30% -304.72% -30.71% -22.76% -15.72% 47.85% 22.32% -10.76% 10.55% 18.66%
Net Income Growth		 -3.64% 116.64% -410.03% -34.39% -20.09% -16.89% 47.92% 21.24% -8.18% 11.72% 18.02%
EPS Growth		 0.00% 117.51% -411.57% -35.98% -19.57% -16.37% 45.60% 19.88% -9.04% 10.63% 17.65%
Operating Cash Flow Growth		 6.22% 18.03% 12.38% -48.36% -7.83% -5.59% 50.38% 5.48% 20.91% 12.04% 18.10%
Free Cash Flow Firm Growth		 102.55% -68.83% 127.50% -851.94% 1.79% 57.51% 123.75% -371.50% 2,548.70% 105.02% -208.61%
Invested Capital Growth		 -6.02% -1.12% -19.76% 74.02% 2.70% 6.75% 15.24% 79.09% 2.79% 32.52% 100.18%
Revenue Q/Q Growth		 -0.65% 1.91% -1.61% 3.91% -1.51% -0.19% 4.35% 6.76% -0.47% 7.18% 6.09%
EBITDA Q/Q Growth		 -15.05% 207.29% -181.19% 3.78% -7.28% -1.11% 3.90% 4.99% -1.52% 3.38% 2.73%
EBIT Q/Q Growth		 -29.29% 128.32% -408.20% 3.56% -11.00% -2.64% 2.61% 6.07% -3.35% 3.80% 1.14%
NOPAT Q/Q Growth		 -34.64% 125.46% -387.71% 9.40% -11.47% -4.24% 5.95% 10.14% -5.17% 3.13% 1.86%
Net Income Q/Q Growth		 -30.83% 116.43% -540.02% 7.51% -9.93% -6.05% 7.01% 10.45% -5.78% 4.03% 1.68%
EPS Q/Q Growth		 -29.03% 117.41% -538.37% 8.04% -10.00% -6.00% 6.84% 9.66% -5.85% 4.12% 1.27%
Operating Cash Flow Q/Q Growth		 0.08% 10.09% -16.76% -2.78% -6.70% -4.68% 14.13% 4.33% -4.27% 9.58% 6.84%
Free Cash Flow Firm Q/Q Growth		 72.65% -59.22% 9.79% 2.63% -3.39% 7.22% 121.96% -351.91% 191.18% -91.51% 7.20%
Invested Capital Q/Q Growth		 -2.32% 2.54% -15.19% -0.89% -0.45% 0.75% 2.20% 65.86% -4.15% 10.82% 1.28%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 44.56% 44.06% 44.12% 45.62% 50.14% 51.29% 53.56% 56.27% 56.01% 58.46% 61.27%
EBITDA Margin		 12.07% 13.00% -11.97% 16.53% 21.99% 24.43% 26.66% 27.28% 27.81% 31.51% 34.92%
Operating Margin		 3.98% 5.59% -20.06% 8.27% 13.77% 17.41% 19.95% 20.97% 20.72% 25.43% 28.88%
EBIT Margin		 4.93% 5.55% -20.04% 8.23% 14.49% 17.70% 20.57% 21.61% 21.55% 25.69% 28.88%
Profit (Net Income) Margin		 3.31% 3.42% -21.18% 6.84% 11.71% 13.88% 17.19% 15.03% 14.33% 17.61% 19.87%
Tax Burden Percent		 67.25% 61.61% 105.71% 83.05% 80.81% 78.40% 83.56% 69.56% 66.50% 68.54% 68.78%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 32.75% 38.39% 0.00% 16.95% 19.19% 21.60% 16.44% 30.44% 33.50% 31.46% 31.22%
Return on Invested Capital (ROIC)		 2.36% 2.95% -10.33% 5.78% 11.58% 15.69% 20.60% 19.24% 22.26% 28.83% 40.43%
ROIC Less NNEP Spread (ROIC-NNEP)		 -0.40% 3.07% 24.82% 5.86% 10.30% 15.05% 18.96% 18.28% 21.29% 28.47% 40.43%
Return on Net Nonoperating Assets (RNNOA)		 0.07% -0.48% -3.23% -1.25% -3.31% -4.39% -5.32% -6.93% -10.18% -13.14% -22.98%
Return on Equity (ROE)		 2.43% 2.47% -13.56% 4.53% 8.27% 11.29% 15.28% 12.31% 12.07% 15.68% 17.45%
Cash Return on Invested Capital (CROIC)		 8.57% 4.08% 11.59% -48.25% 8.91% 9.16% 6.44% -37.43% 19.51% 0.85% -26.32%
Operating Return on Assets (OROA)		 3.26% 3.55% -11.31% 4.80% 8.88% 12.56% 16.11% 15.96% 16.57% 20.94% 23.41%
Return on Assets (ROA)		 2.19% 2.19% -11.96% 3.99% 7.18% 9.85% 13.46% 11.10% 11.02% 14.35% 16.10%
Return on Common Equity (ROCE)		 2.43% 2.47% -13.56% 4.53% 8.27% 11.29% 15.28% 12.31% 12.07% 15.68% 17.45%
Return on Equity Simple (ROE_SIMPLE)		 2.48% 2.48% -14.83% 4.03% 7.89% 10.87% 14.14% 11.23% 11.24% 14.20% 15.68%
Net Operating Profit after Tax (NOPAT)		 13 17 -69 34 48 63 74 50 41 46 42
NOPAT Margin		 2.67% 3.44% -14.04% 6.86% 11.13% 13.65% 16.67% 14.58% 13.78% 17.43% 19.86%
Net Nonoperating Expense Percent (NNEP)		 2.76% -0.12% -35.16% -0.08% 1.27% 0.64% 1.64% 0.96% 0.96% 0.36% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 2.00% 2.50% -9.83% - - - - - - - -
Cost of Revenue to Revenue		 55.44% 55.94% 55.88% 54.38% 49.86% 48.71% 46.44% 43.73% 43.99% 41.54% 38.74%
SG&A Expenses to Revenue		 12.84% 13.06% 13.83% 11.46% 11.91% 10.85% 11.78% 11.96% 12.30% 11.25% 10.56%
R&D to Revenue		 8.24% 7.97% 7.83% 9.06% 8.50% 7.13% 6.45% 6.84% 7.51% 6.95% 7.92%
Operating Expenses to Revenue		 40.59% 38.47% 64.18% 37.36% 36.37% 33.88% 33.61% 35.30% 35.29% 33.04% 32.38%
Earnings before Interest and Taxes (EBIT)		 25 28 -98 40 63 81 92 74 64 68 61
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 60 65 -58 81 96 112 119 94 83 83 73
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.43 1.44 0.99 1.71 6.37 4.64 5.64 5.95 3.57 5.09 0.00
Price to Tangible Book Value (P/TBV)		 2.56 2.54 1.76 3.63 8.19 6.18 7.77 8.75 3.90 5.64 0.00
Price to Revenue (P/Rev)		 1.91 1.99 1.42 2.90 9.45 5.92 6.85 7.97 4.55 6.31 0.00
Price to Earnings (P/E)		 57.74 58.34 0.00 42.45 80.68 42.69 39.87 53.01 31.78 35.82 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 1.73% 1.71% 0.00% 2.36% 1.24% 2.34% 2.51% 1.89% 3.15% 2.79% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.52 1.53 0.99 1.80 9.17 6.17 7.51 7.81 6.22 8.36 0.00
Enterprise Value to Revenue (EV/Rev)		 1.67 1.77 1.20 2.71 8.94 5.55 6.50 7.60 3.91 5.76 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 13.84 13.65 0.00 16.42 40.64 22.70 24.40 27.86 14.05 18.27 0.00
Enterprise Value to EBIT (EV/EBIT)		 33.93 31.98 0.00 32.97 61.69 31.33 31.62 35.18 18.13 22.41 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 62.52 51.51 0.00 39.54 80.30 40.63 39.01 52.12 28.35 33.04 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 10.76 12.20 9.44 23.98 36.30 21.92 23.57 32.03 15.03 23.73 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 17.24 37.27 7.61 0.00 104.34 69.58 124.84 0.00 32.35 1,119.01 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.17 -0.16 -0.13 -0.21 -0.32 -0.29 -0.28 -0.38 -0.48 -0.46 -0.57
Leverage Ratio		 1.11 1.13 1.13 1.14 1.15 1.15 1.13 1.11 1.10 1.09 1.08
Compound Leverage Factor		 1.11 1.13 1.13 1.14 1.15 1.15 1.13 1.11 1.10 1.09 1.08
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.07% 0.00% 0.00% 0.06%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.07% 0.00% 0.00% 0.05%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 98.93% 100.00% 100.00% 99.94%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.34 0.00 0.00 -1.75
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.51 0.00 0.00 -3.08
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 9.31 9.29 4.80 9.90 26.52 20.64 25.82 30.65 25.89 32.19 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.66 4.04 2.61 3.34 4.82 4.97 4.08 3.77 6.74 5.25 5.75
Quick Ratio		 3.18 3.54 2.18 2.87 4.37 4.58 3.62 3.33 6.08 4.45 5.24
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 49 24 77 -280 37 37 23 -98 36 1.36 -27
Operating Cash Flow to CapEx		 851.99% 267.26% 353.16% 161.48% 227.55% 186.49% 141.13% 250.49% 230.54% 144.48% 131.50%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.66 0.64 0.56 0.58 0.61 0.71 0.78 0.74 0.77 0.82 0.81
Accounts Receivable Turnover		 7.19 6.76 6.25 7.08 7.53 7.87 8.05 8.05 8.49 8.75 9.85
Inventory Turnover		 21.39 20.70 20.41 22.10 20.69 22.16 19.38 14.64 13.74 13.74 14.29
Fixed Asset Turnover		 2.08 1.97 1.82 1.73 1.59 1.87 2.26 2.25 2.25 2.43 2.84
Accounts Payable Turnover		 17.83 17.09 12.78 12.17 12.36 13.06 12.43 11.08 10.50 10.19 11.32
Days Sales Outstanding (DSO)		 50.77 53.99 58.40 51.57 48.45 46.39 45.32 45.33 42.97 41.70 37.05
Days Inventory Outstanding (DIO)		 17.06 17.63 17.88 16.52 17.64 16.47 18.84 24.93 26.56 26.56 25.54
Days Payable Outstanding (DPO)		 20.47 21.36 28.57 29.99 29.54 27.95 29.36 32.95 34.75 35.81 32.23
Cash Conversion Cycle (CCC)		 47.37 50.27 47.71 38.10 36.56 34.91 34.80 37.31 34.78 32.45 30.36
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 549 584 591 737 423 412 386 335 187 182 137
Invested Capital Turnover		 0.88 0.86 0.74 0.84 1.04 1.15 1.24 1.32 1.62 1.65 2.04
Increase / (Decrease) in Invested Capital		 -35 -6.63 -146 313 11 26 51 148 5.08 45 69
Enterprise Value (EV)		 837 894 586 1,325 3,883 2,544 2,898 2,618 1,165 1,521 0.00
Market Capitalization		 958 1,005 692 1,417 4,104 2,717 3,053 2,745 1,357 1,666 0.00
Book Value per Share		 $27.34 $26.96 $25.73 $30.03 $24.08 $21.89 $20.00 $17.31 $14.37 $12.52 $10.34
Tangible Book Value per Share		 $15.29 $15.35 $14.47 $14.13 $18.74 $16.43 $14.51 $11.77 $13.18 $11.29 $9.05
Total Capital		 670 695 698 828 644 586 541 466 380 328 266
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.00 0.00 0.00 0.15
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
Net Debt		 -121 -111 -107 -92 -221 -174 -155 -126 -193 -146 -128
Capital Expenditures (CapEx)		 9.14 27 18 34 47 62 87 33 34 44 44
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 38 48 35 51 30 28 31 32 26 31 15
Debt-free Net Working Capital (DFNWC)		 142 151 115 129 192 189 163 126 134 112 89
Net Working Capital (NWC)		 142 151 115 129 192 189 163 121 134 112 89
Net Nonoperating Expense (NNE)		 -3.20 0.13 35 0.13 -2.51 -1.05 -2.30 -1.54 -1.63 -0.49 -0.00
Net Nonoperating Obligations (NNO)		 -121 -111 -107 -92 -221 -174 -155 -126 -193 -146 -128
Total Depreciation and Amortization (D&A)		 36 38 39 40 33 31 27 20 19 15 13
Debt-free, Cash-free Net Working Capital to Revenue		 7.68% 9.56% 7.14% 10.47% 6.92% 6.14% 6.92% 9.32% 8.75% 11.69% 7.26%
Debt-free Net Working Capital to Revenue		 28.27% 29.96% 23.54% 26.35% 44.14% 41.17% 36.50% 36.65% 45.08% 42.31% 42.58%
Net Working Capital to Revenue		 28.27% 29.96% 23.54% 26.35% 44.14% 41.17% 36.50% 35.20% 45.08% 42.31% 42.51%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.66 $0.66 ($3.77) $1.21 $1.90 $2.37 $2.84 $1.94 $1.62 $1.79 $1.62
Adjusted Weighted Average Basic Shares Outstanding		 25.10M 26.19M 27.41M 27.62M 26.74M 26.87M 26.98M 26.65M 26.37M 26.01M 25.69M
Adjusted Diluted Earnings per Share		 $0.66 $0.66 ($3.77) $1.21 $1.89 $2.35 $2.81 $1.93 $1.61 $1.77 $1.60
Adjusted Weighted Average Diluted Shares Outstanding		 25.21M 26.22M 27.41M 27.65M 26.90M 27.05M 27.28M 26.85M 26.56M 26.32M 26.10M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 24.23M 25.72M 26.68M 27.47M 27.60M 26.79M 26.98M 26.90M 26.53M 26.20M 25.87M
Normalized Net Operating Profit after Tax (NOPAT)		 17 17 19 34 48 63 74 50 41 46 42
Normalized NOPAT Margin		 3.42% 3.47% 3.86% 6.86% 11.13% 13.65% 16.67% 14.58% 13.78% 17.43% 19.86%
Pre Tax Income Margin		 4.93% 5.55% -20.04% 8.23% 14.49% 17.70% 20.57% 21.61% 21.55% 25.69% 28.88%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.94% 3.01% 2.88%
Augmented Payout Ratio		 363.27% 255.23% -28.67% 69.76% 28.87% 52.66% 15.97% 8.52% 0.94% 3.01% 2.88%

Quarterly Metrics And Ratios for Proto Labs

This table displays calculated financial ratios and metrics derived from Proto Labs' official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -1.32% -2.64% -3.89% 2.75% 1.61% 8.17% 7.38% -3.65% 1.36% -6.45% -2.89%
EBITDA Growth		 -12.78% -55.63% -6.42% 39.17% 16.65% 117.95% 27.47% -23.02% -19.05% -562.54% -9.22%
EBIT Growth		 -22.53% -102.84% -8.08% 228.57% 53.32% 108.52% 77.91% -56.94% -33.61% -1,002.44% -14.57%
NOPAT Growth		 -41.47% -117.72% -19.00% 485.92% 135.31% 107.20% 94.54% -137.51% -62.65% -782.21% -16.35%
Net Income Growth		 -31.68% -105.78% -9.62% 1,285.38% 98.12% 106.07% 101.32% -114.98% -47.81% -1,066.12% -18.28%
EPS Growth		 -25.00% -103.85% -6.45% 1,900.00% 100.00% 106.21% 121.43% -111.11% -47.37% -1,052.27% -17.65%
Operating Cash Flow Growth		 -13.87% 0.38% 2.38% 55.49% -5.49% 63.84% 17.81% -29.93% 26.96% -54.32% 78.53%
Free Cash Flow Firm Growth		 320.72% 172.35% -89.68% -91.28% -94.14% -80.28% 168.20% 241.97% 2,322.14% 121.09% 116.03%
Invested Capital Growth		 -5.89% -6.02% -1.34% -1.31% -0.70% -1.12% -18.22% -18.39% -20.19% -19.76% -6.22%
Revenue Q/Q Growth		 3.66% -3.08% -0.01% -1.77% 2.27% -4.33% 6.90% -2.86% 8.87% -5.02% -4.08%
EBITDA Q/Q Growth		 71.85% -54.51% 14.97% -2.95% -12.59% -4.05% 70.98% -18.66% 113.45% -781.40% 3.26%
EBIT Q/Q Growth		 2,222.34% -102.86% 34.08% -4.74% -22.26% -7.42% 379.24% -55.55% 104.32% -2,034.09% 15.99%
NOPAT Q/Q Growth		 360.36% -116.74% 68.92% -20.51% -21.16% -23.48% 904.79% -148.47% 102.41% -2,167.01% 55.16%
Net Income Q/Q Growth		 990.84% -105.62% 58.35% -13.82% -24.64% -12.12% 2,176.76% -114.40% 102.31% -3,012.30% 54.52%
EPS Q/Q Growth		 1,600.00% -103.45% 61.11% -10.00% -23.08% -16.13% 3,200.00% -110.00% 102.39% -3,092.86% 55.56%
Operating Cash Flow Q/Q Growth		 6.27% -30.14% 71.39% -32.31% 23.86% -28.75% 160.30% -58.86% 114.72% -48.77% 54.82%
Free Cash Flow Firm Q/Q Growth		 7.12% 145.62% 22.91% 30.10% -30.66% -90.69% 3.82% -12.51% 133.31% 26.55% 32.38%
Invested Capital Q/Q Growth		 -1.59% -2.32% -1.74% -0.36% -1.73% 2.54% -1.71% 0.26% -2.15% -15.19% -1.92%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 44.13% 42.68% 45.56% 45.01% 44.93% 44.63% 45.36% 43.45% 42.73% 42.05% 44.06%
EBITDA Margin		 11.63% 7.02% 14.95% 13.00% 13.16% 15.40% 15.35% 9.60% 11.46% -92.78% 12.93%
Operating Margin		 3.59% -1.23% 6.83% 4.78% 5.34% 6.71% 7.97% 4.59% 2.98% -101.32% 4.98%
EBIT Margin		 4.74% -0.23% 7.86% 5.86% 6.04% 7.95% 8.21% 1.83% 4.00% -100.95% 4.96%
Profit (Net Income) Margin		 2.85% -0.33% 5.72% 3.61% 4.12% 5.59% 6.09% -0.31% 2.11% -99.53% 3.25%
Tax Burden Percent		 60.13% 143.26% 72.85% 61.68% 68.19% 70.34% 74.09% -17.10% 52.77% 98.60% 65.48%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 39.87% 0.00% 27.15% 38.32% 31.81% 29.66% 25.91% 117.10% 47.23% 0.00% 34.52%
Return on Invested Capital (ROIC)		 1.93% -0.76% 4.43% 2.60% 3.19% 4.05% 4.61% -0.59% 1.18% -52.18% 2.25%
ROIC Less NNEP Spread (ROIC-NNEP)		 1.17% -1.31% 3.62% 1.83% 2.63% 3.05% 4.40% -1.13% 0.54% -18.84% 2.26%
Return on Net Nonoperating Assets (RNNOA)		 -0.20% 0.22% -0.62% -0.29% -0.42% -0.48% -0.67% 0.16% -0.08% 2.45% -0.27%
Return on Equity (ROE)		 1.73% -0.54% 3.81% 2.32% 2.78% 3.57% 3.94% -0.43% 1.11% -49.73% 1.98%
Cash Return on Invested Capital (CROIC)		 8.13% 8.57% 4.97% 5.12% 4.21% 4.08% 9.28% 9.22% 11.48% 11.59% 9.73%
Operating Return on Assets (OROA)		 3.14% -0.15% 5.15% 3.89% 3.92% 5.09% 4.80% 1.05% 2.27% -56.97% 2.68%
Return on Assets (ROA)		 1.89% -0.22% 3.75% 2.40% 2.67% 3.58% 3.56% -0.18% 1.20% -56.17% 1.75%
Return on Common Equity (ROCE)		 1.73% -0.54% 3.81% 2.32% 2.78% 3.57% 3.94% -0.43% 1.11% -49.73% 1.98%
Return on Equity Simple (ROE_SIMPLE)		 2.27% 0.00% 3.53% 3.61% 2.89% 0.00% -15.31% -15.94% -15.50% 0.00% 2.90%
Net Operating Profit after Tax (NOPAT)		 2.72 -1.05 6.25 3.70 4.66 5.90 7.72 -0.96 1.98 -82 3.97
NOPAT Margin		 2.16% -0.86% 4.98% 2.95% 3.64% 4.72% 5.90% -0.78% 1.57% -70.92% 3.26%
Net Nonoperating Expense Percent (NNEP)		 0.76% 0.55% 0.81% 0.78% 0.56% 1.00% 0.21% 0.54% 0.64% -33.34% -0.02%
Return On Investment Capital (ROIC_SIMPLE)		 0.41% -0.16% - - - 0.85% - - - -11.75% -
Cost of Revenue to Revenue		 55.87% 57.32% 54.44% 54.99% 55.07% 55.37% 54.64% 56.55% 57.27% 57.96% 55.94%
SG&A Expenses to Revenue		 13.35% 12.46% 12.94% 13.21% 12.76% 12.86% 13.05% 12.94% 13.37% 15.37% 13.54%
R&D to Revenue		 8.41% 7.97% 7.78% 8.49% 8.73% 7.59% 7.73% 8.07% 8.48% 7.70% 7.65%
Operating Expenses to Revenue		 40.54% 43.90% 38.73% 40.23% 39.60% 37.92% 37.39% 38.86% 39.75% 143.36% 39.08%
Earnings before Interest and Taxes (EBIT)		 5.99 -0.28 9.87 7.36 7.73 9.94 11 2.24 5.04 -117 6.03
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 15 8.54 19 16 17 19 20 12 14 -107 16
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.29 1.43 1.09 1.14 1.34 1.44 1.01 1.34 1.29 0.99 1.24
Price to Tangible Book Value (P/TBV)		 2.35 2.56 1.93 2.02 2.37 2.54 1.79 2.41 2.33 1.76 2.53
Price to Revenue (P/Rev)		 1.70 1.91 1.46 1.54 1.82 1.99 1.39 1.89 1.80 1.42 2.02
Price to Earnings (P/E)		 56.90 57.74 30.79 31.59 46.49 58.34 0.00 0.00 0.00 0.00 42.61
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 1.76% 1.73% 3.25% 3.17% 2.15% 1.71% 0.00% 0.00% 0.00% 0.00% 2.35%
Enterprise Value to Invested Capital (EV/IC)		 1.36 1.52 1.10 1.17 1.41 1.53 1.01 1.40 1.35 0.99 1.27
Enterprise Value to Revenue (EV/Rev)		 1.47 1.67 1.23 1.31 1.60 1.77 1.16 1.68 1.59 1.20 1.79
Enterprise Value to EBITDA (EV/EBITDA)		 12.56 13.84 8.72 9.23 11.92 13.65 0.00 0.00 0.00 0.00 12.33
Enterprise Value to EBIT (EV/EBIT)		 31.96 33.93 17.80 18.71 26.40 31.98 0.00 0.00 0.00 0.00 27.96
Enterprise Value to NOPAT (EV/NOPAT)		 63.93 62.52 30.31 30.55 40.00 51.51 0.00 0.00 0.00 0.00 37.25
Enterprise Value to Operating Cash Flow (EV/OCF)		 9.79 10.76 7.99 8.67 11.23 12.20 8.62 12.93 11.66 9.44 11.91
Enterprise Value to Free Cash Flow (EV/FCFF)		 16.18 17.24 22.07 22.68 33.35 37.27 9.76 13.67 10.42 7.61 12.67
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.17 -0.17 -0.17 -0.16 -0.16 -0.16 -0.15 -0.14 -0.14 -0.13 -0.12
Leverage Ratio		 1.12 1.11 1.13 1.12 1.14 1.13 1.13 1.13 1.14 1.13 1.12
Compound Leverage Factor		 1.12 1.11 1.13 1.12 1.14 1.13 1.13 1.13 1.14 1.13 1.12
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 7.69 9.20 7.41 7.85 8.09 9.22 5.48 7.08 6.16 4.73 7.59
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.13 3.66 3.59 4.08 3.60 4.04 2.74 2.80 2.41 2.61 3.17
Quick Ratio		 2.75 3.18 3.16 3.61 3.21 3.54 2.43 2.44 2.07 2.18 2.72
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 37 34 14 11 8.69 13 135 130 148 64 50
Operating Cash Flow to CapEx		 1,456.34% 2,083.61% 1,596.00% 344.78% 831.89% 94.79% 796.41% 313.92% 695.35% 239.47% 286.77%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.66 0.66 0.66 0.66 0.65 0.64 0.58 0.57 0.57 0.56 0.54
Accounts Receivable Turnover		 6.58 7.19 6.82 6.98 6.51 6.76 6.22 6.16 5.99 6.25 5.97
Inventory Turnover		 21.35 21.39 21.14 21.01 20.68 20.70 19.68 18.82 19.41 20.41 22.44
Fixed Asset Turnover		 2.13 2.08 2.10 2.07 2.02 1.97 1.97 1.91 1.87 1.82 1.83
Accounts Payable Turnover		 17.61 17.83 16.83 17.30 15.96 17.09 16.06 17.21 14.81 12.78 13.83
Days Sales Outstanding (DSO)		 55.48 50.77 53.52 52.29 56.08 53.99 58.69 59.21 60.91 58.40 61.12
Days Inventory Outstanding (DIO)		 17.10 17.06 17.27 17.37 17.65 17.63 18.55 19.39 18.80 17.88 16.27
Days Payable Outstanding (DPO)		 20.72 20.47 21.68 21.09 22.87 21.36 22.72 21.21 24.65 28.57 26.38
Cash Conversion Cycle (CCC)		 51.85 47.37 49.10 48.57 50.86 50.27 54.52 57.39 55.07 47.71 51.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 541 549 562 572 574 584 570 580 578 591 697
Invested Capital Turnover		 0.90 0.88 0.89 0.88 0.88 0.86 0.78 0.75 0.75 0.74 0.69
Increase / (Decrease) in Invested Capital		 -34 -35 -7.65 -7.61 -4.04 -6.63 -127 -131 -146 -146 -46
Enterprise Value (EV)		 733 837 621 669 809 894 574 813 780 586 888
Market Capitalization		 849 958 739 782 922 1,005 689 916 884 692 1,002
Book Value per Share		 $27.10 $27.34 $27.04 $27.07 $26.82 $26.96 $26.25 $26.05 $25.61 $25.73 $29.48
Tangible Book Value per Share		 $14.94 $15.29 $15.23 $15.32 $15.18 $15.35 $14.73 $14.52 $14.22 $14.47 $14.38
Total Capital		 657 670 680 685 687 695 685 683 683 698 811
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -116 -121 -118 -113 -113 -111 -115 -103 -105 -107 -114
Capital Expenditures (CapEx)		 1.26 0.83 1.55 4.19 2.57 18 3.04 2.96 3.25 4.39 7.16
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 35 38 39 44 42 48 27 32 25 35 47
Debt-free Net Working Capital (DFNWC)		 132 142 139 157 152 151 130 119 110 115 132
Net Working Capital (NWC)		 132 142 139 157 152 151 130 119 110 115 132
Net Nonoperating Expense (NNE)		 -0.87 -0.64 -0.94 -0.84 -0.61 -1.09 -0.24 -0.58 -0.68 33 0.02
Net Nonoperating Obligations (NNO)		 -116 -121 -118 -113 -113 -111 -115 -103 -105 -107 -114
Total Depreciation and Amortization (D&A)		 8.69 8.82 8.91 8.97 9.10 9.32 9.33 9.50 9.39 9.44 9.71
Debt-free, Cash-free Net Working Capital to Revenue		 7.11% 7.68% 7.70% 8.59% 8.36% 9.56% 5.50% 6.69% 5.19% 7.14% 9.47%
Debt-free Net Working Capital to Revenue		 26.51% 28.27% 27.63% 30.76% 30.04% 29.96% 26.27% 24.50% 22.51% 23.54% 26.52%
Net Working Capital to Revenue		 26.51% 28.27% 27.63% 30.76% 30.04% 29.96% 26.27% 24.50% 22.51% 23.54% 26.52%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.15 ($0.02) $0.29 $0.18 $0.21 $0.26 $0.31 ($0.01) $0.10 ($4.19) $0.14
Adjusted Weighted Average Basic Shares Outstanding		 24.14M 25.10M 24.98M 25.31M 25.62M 26.19M 26.02M 26.21M 26.58M 27.41M 27.51M
Adjusted Diluted Earnings per Share		 $0.15 ($0.01) $0.29 $0.18 $0.20 $0.26 $0.31 ($0.01) $0.10 ($4.19) $0.14
Adjusted Weighted Average Diluted Shares Outstanding		 24.44M 25.21M 25.02M 25.37M 25.78M 26.22M 26.03M 26.21M 26.61M 27.41M 27.51M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 23.77M 24.23M 24.51M 25.15M 25.32M 25.72M 25.79M 26.10M 26.20M 26.68M 27.12M
Normalized Net Operating Profit after Tax (NOPAT)		 2.72 -1.05 6.25 3.70 4.66 5.90 7.72 3.93 1.98 -82 3.97
Normalized NOPAT Margin		 2.16% -0.86% 4.98% 2.95% 3.64% 4.72% 5.90% 3.21% 1.57% -70.92% 3.26%
Pre Tax Income Margin		 4.74% -0.23% 7.86% 5.86% 6.04% 7.95% 8.21% 1.83% 4.00% -100.95% 4.96%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 436.58% 363.27% 212.01% 164.94% 195.90% 255.23% -53.07% -50.06% -47.95% -28.67% 99.17%

Frequently Asked Questions About Proto Labs' Financials

When does Proto Labs's financial year end?

According to the most recent income statement we have on file, Proto Labs' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Proto Labs' net income changed over the last 10 years?

Proto Labs' net income appears to be on a downward trend, with a most recent value of $16.59 million in 2024, falling from $41.64 million in 2014. The previous period was $17.22 million in 2023. See where experts think Proto Labs is headed by visiting Proto Labs' forecast page.

What is Proto Labs's operating income?
Proto Labs's total operating income in 2024 was $19.91 million, based on the following breakdown:
  • Total Gross Profit: $223.20 million
  • Total Operating Expenses: $203.29 million
How has Proto Labs revenue changed over the last 10 years?

Over the last 10 years, Proto Labs' total revenue changed from $209.58 million in 2014 to $500.89 million in 2024, a change of 139.0%.

How much debt does Proto Labs have?

Proto Labs' total liabilities were at $73.36 million at the end of 2024, a 4.8% decrease from 2023, and a 241.3% increase since 2014.

How much cash does Proto Labs have?

In the past 10 years, Proto Labs' cash and equivalents has ranged from $36.71 million in 2017 to $127.60 million in 2020, and is currently $89.07 million as of their latest financial filing in 2024.

How has Proto Labs' book value per share changed over the last 10 years?

Over the last 10 years, Proto Labs' book value per share changed from 10.34 in 2014 to 27.34 in 2024, a change of 164.6%.


Related Companies

This page (NYSE:PRLB) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Gold Alert: The Truth About Fort Knox Is Coming
Owning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...
Golden Portfolio | Sponsored
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored